Early Phase 1 Parkinson's Disease Clinical Trials
5 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease
Parkinson's DiseaseParkinson's Disease (PD)Parkinson's Disease (Disorder)
Invicro22 enrolled1 locationNCT07348250
Recruiting
Early Phase 1
PET Imaging Evaluation of [11C]SY08
Multiple System AtrophyDementia With Lewy BodiesParkinson's Disease
Massachusetts General Hospital40 enrolled1 locationNCT06098612
Recruiting
Early Phase 1
[18F]ACI-15916 PET in α-synucleinopathies
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA46 enrolled1 locationNCT06891703
Recruiting
Early Phase 1
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
Advanced Parkinson's Disease
Second Affiliated Hospital of Soochow University8 enrolled1 locationNCT06195124
Recruiting
Early Phase 1
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
Overactive BladderParkinson's DiseaseOnabotulinumtoxin A
Zhujiang Hospital60 enrolled1 locationNCT05997043